bioRxiv Science⌕ Search

SEARCH · bioRxiv Science

Results for “cancer biology”

Search indexed bioRxiv preprints in genomics, neuroscience, cell biology and bioinformatics. Read source abstracts and check manuscript versions; preprints are not peer reviewed.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 217 records · Page 12Linked to original sources

From Circles to Signals: Representation Learning on Ultra-Long Extrachromosomal Circular DNA

Extrachromosomal circular DNA (eccDNA) is a covalently closed circular DNA molecule that plays an important role in cancer biology. Genomic foundation models have recently emerged as a powerful direction for DNA sequence modeling, enabling the direct prediction of biologically relevant properties from DNA sequences. Although recent genomic foundation models have shown strong performance on general DNA sequence modeling, their application to eccDNA remains limited: existing approaches either rely on computationally expensive attention mechanisms or truncate ultra-long sequences into kilobase fragments, thereby disrupting long-range continuity and ignoring the molecules circular topology. To overcome these problems, we introduce eccDNAMamba, a bidirectional state space model (SSM) built upon the Mamba-2 framework, which scales linearly with input sequence length and enables scalable modeling of ultra-long eccDNA sequences. eccDNAMamba further incorporates a circular augmentation strategy to preserve the intrinsic circular topology of eccDNA. Comprehensive evaluations against state-of-the-art genomic foundation models demonstrate that eccDNAMamba achieves superior performance on ultra-long sequences across multiple task settings, such as cancer versus healthy eccDNA discrimination and eccDNA copy-number level prediction. Moreover, the Integrated Gradient (IG) based model explanation indicates that eccDNAMamba focuses on biologically meaningful regulatory elements and can uncover key sequence patterns in cancer-derived eccDNAs. Overall, these results demonstrate that eccDNAMamba effectively models ultra-long eccDNA sequences by leveraging their unique circular topology and regulatory architecture, bridging a critical gap in sequence analysis. Our codes and datasets are available at https://github.com/zzq1zh/eccDNAMamba.

bioinformatics↗

Exploring Protein Patterns, Cavity Interactions, and Therapeutic Insights in Cancer

Protein sequence alignments are essential for identifying proteins shared structural and functional features. Detecting short amino acid sequences, termed patterns, across lung cancer and other related datasets facilitates the identification of relevant features. This study builds on previous findings by exploring proteins that share common patterns already identified. Using sequence matching at 5% and 10% occurrence thresholds, we identified 2,368 and 47 patterns, respectively. To reduce complexity and refine the dataset, shorter patterns from the 10% occurrence streamlined the analysis by isolating highly relevant patterns while reducing redundancy among proteins sharing sequence segments. Subsequent analyses integrated structural predictions for protein folding comparison, enabling the detection of patterns in different proteins and the identification of potential key residues. During cavity detection prediction, some amino acids were inspected in detail to assess their impact on protein function and their relevance in drug-target interactions. These insights were considered during docking studies, focusing on proteins used in treatments with pre-described ligands. By connecting raw sequence data to folding structures and functional features, we identified critical protein cavities that underscore the role of mutations in altering protein behavior and influencing drug-target interactions. These findings highlight protein activitys structural foundations and their importance in understanding cancer biology. By uncovering conserved sequence patterns and their structural implications, this study provides insights into potential biomarkers and therapeutic targets, that could aid in developing more effective cancer treatments.

bioinformatics↗

Network-Based Matching of Patients and Targeted Therapies for Precision Oncology

The extensive acquisition of high-throughput molecular profiling data across model systems (human tumors and cancer cell lines) and drug sensitivity data, makes precision oncology possible - allowing clinicians to match the right drug to the right patient. Current supervised models for drug sensitivity prediction, often use cell lines as exemplars of patient tumors and for model training. However, these models are limited in their ability to accurately predict drug sensitivity of individual cancer patients to a large set of drugs, given the paucity of patient drug sensitivity data used for testing and high variability across different drugs. To address these challenges, we developed a multilayer network-based approach to impute individual patients responses to a large set of drugs. This approach considers the triplet of patients, cell lines and drugs as one inter-connected holistic system. We first use the omics profiles to construct a patient-cell line network and determine best matching cell lines for patient tumors based on robust measures of network similarity. Subsequently, these results are used to impute the \"missing link\" between each individual patient and each drug, called Personalized Imputed Drug Sensitivity Score (PIDS-Score), which can be construed as a measure of the therapeutic potential of a drug or therapy. We applied our method to two subtypes of lung cancer patients, matched these patients with cancer cell lines derived from 19 tissue types based on their functional proteomics profiles, and computed their PIDS-Scores to 251 drugs and experimental compounds. We identified the best representative cell lines that conserve lung cancer biology and molecular targets. The PIDS-Score based top sensitive drugs for the entire patient cohort as well as individual patients are highly related to lung cancer in terms of their targets, and their PIDS-Scores are significantly associated with patient clinical outcomes. These findings provide evidence that our method is useful to narrow the scope of possible effective patient-drug matchings for implementing evidence-based personalized medicine strategies.\n\nData and code availabilityhttps://github.com/bayesrx/bayesrx.github.io/tree/master/authors/liu-q./ Shiny app (data and results visualization tool): https://qingzliu.shinyapps.io/psb-app/

bioinformatics↗

The shape of gene expression distributions matter: how incorporating distribution shape improves the interpretation of cancer transcriptomic data

In genomics, we often impose the assumption that gene expression data follows a specific distribution. However, rarely do we stop to question this assumption or consider its applicability to all genes in the transcriptome. Our study investigated the prevalence of genes with expression distributions that are non-Normal in three different tumor types from the Cancer Genome Atlas (TCGA). Surprisingly, less than 50% of all genes were Normally-distributed, with other distributions including Gamma, Bimodal, Cauchy, and Lognormal were represented. Relevant information about cancer biology was captured by the genes with non-Normal gene expression. When used for classification, the set of non-Normal genes were able to discriminate between cancer patients with poor versus good survival status. Our results highlight the value of studying a genes distribution shape to model heterogeneity of transcriptomic data. These insights would have been overlooked when using standard approaches that assume all genes follow the same type of distribution in a patient cohort.

bioinformatics↗

AI-Enhanced RAIN Protocol: A Systematic Approach to Optimize Drug Combinations for Rectal Neoplasm Treatment

BackgroundRectal cancers, or rectal neoplasms, are tumors that develop from the lining of the rectum, the concluding part of the large intestine ending at the anus. These tumors often start as benign polyps and may evolve into malignancies over several years. The causes of rectal cancer are diverse, with genetic mutations being a key factor. These mutations lead to uncontrolled cell growth, resulting in tumors that can spread and damage healthy tissue. Age, genetic predisposition, diet, and hereditary conditions are among the risk factors. Treating rectal cancer is critical to prevent severe health issues and death. Untreated, it can cause intestinal blockage, metastasis, and deteriorate the patients quality of life. Effective treatment hinges on finding the right drug combinations to improve therapeutic outcomes. Given the intricacies of cancer biology, treatments often combine surgery, chemotherapy, and radiation, with drugs chosen to target different tumor growth mechanisms, aiming to reduce the tumor and limit side effects. The continuous advancement in cancer treatments highlights the need for ongoing research to discover new drug combinations, offering patients improved recovery prospects and a better quality of life. This background encapsulates a detailed yet succinct understanding of rectal neoplasms, their origins, the urgency of treatment, and the quest for effective drug therapies, paving the way for discussions on treatment advancements and patient care impacts. MethodThis study employed the RAIN protocol, comprising three steps: firstly, utilizing the GraphSAGE model to propose drug combinations for rectal neoplasm treatment Each node in the graph model is a drug or a human gene/protein that acts as potential target for the disease, and the edges are P-values between them; secondly, conducting a systematic review across various databases including Web of Science, Google Scholar, Scopus, Science Direct, PubMed, and Embase, with NLP investigation; and thirdly, employing a meta-analysis network to assess the efficacy of drugs and genes in relation to each other. All implementations was conducted using Python software. ResultThe study evaluated the efficacy of Oxaliplatin, Leucovorin, and Capecitabine in treating Rectal Neoplasms, confirming their effectiveness through a review of 30 studies. The p-values for individual drugs were 0.019, 0.019, and 0.016 respectively, while the combined use of all three yielded a p-value of 0.016. ConclusionGiven the significance of rectal neoplasms, policymakers are urged to prioritize the healthcare needs of affected individuals. Utilizing artificial intelligence within the RAIN protocol can offer valuable insights for tailoring effective drug combinations to better address the treatment and management of rectal neoplasms patients. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=90 SRC="FIGDIR/small/596215v1_ufig1.gif" ALT="Figure 1"> View larger version (34K): org.highwire.dtl.DTLVardef@1967f95org.highwire.dtl.DTLVardef@1921c52org.highwire.dtl.DTLVardef@181809dorg.highwire.dtl.DTLVardef@122d8b4_HPS_FORMAT_FIGEXP M_FIG C_FIG HighlightsO_LIRectal cancers, evolving from benign polyps to malignancies, underscore the critical need for timely and effective treatment to prevent severe health complications. C_LIO_LIGenetic mutations, a pivotal factor in rectal cancer, trigger uncontrolled cell growth and necessitate targeted drug therapies to combat tumor spread. C_LIO_LIThe RAIN protocol, leveraging the GraphSAGE model and systematic reviews, offers a novel approach to identify potent drug combinations for rectal neoplasm treatment. C_LIO_LIThe studys findings advocate for policy intervention to ensure that healthcare systems adequately support individuals battling rectal neoplasms, with AI-driven protocols enhancing patient care. C_LI

bioinformatics↗

Unraveling tumor heterogeneity: Quantitative insights from scRNA-seq analysis in breast cancer subtypes

Tumors are complex systems characterized by genetic, transcriptomic, phenotypic, and microenvironmental variations. The complexity of this heterogeneity plays a crucial role in metastasis, tumor progression, and recurrence. In this work, we utilized publicly available single-cell transcriptomics data from human breast cancer samples (ER+, HER2+, and triple-negative) to evaluate key concepts pertinent to cancer biology. Quantitative assessments included measures based on copy number alterations (CNAs), entropy, transcriptomic heterogeneity, and different protein-protein interaction networks (PPINs). We found that entropy and PPIN activity related to the cell cycle delineate cell clusters with notably elevated mitotic activity, particularly elevated in aggressive breast cancer subtypes. Additionally, CNA distributions differentiate between ER+ and HER2+/TN subtypes. Further, we identified positive correlations among the CNA score, entropy, and the activities of PPINs associated with the cell cycle, as well as basal and mesenchymal cell lines. These scores reveal associations with tumor characteristics, reflecting the known malignancy spectrum across breast cancer subtypes. By bridging the gap between existing literature and a comprehensive quantitative approach, we present a novel framework for quantifying cancer traits from scRNA-seq data by establishing several scores. This approach highlights the potential for deeper insights into tumor biology compared to conventional marker-based approaches.

bioinformatics↗

High school Internship Program in Integrated Mathematical Oncology (HIP IMO) - five-year experience at Moffitt Cancer Center

Modern cancer research, and the wealth of data across multiple spatial and temporal scales, has created the need for researchers that are well-versed in the life sciences (cancer biology, developmental biology, immunology), medical sciences (oncology) and natural sciences (mathematics, physics, engineering, computer sciences). College undergraduate education is traditionally provided in disciplinary silos, which creates a steep learning curve at the graduate and postdoctoral levels that increasingly bridge multiple disciplines. Numerous colleges have begun to embrace interdisciplinary curricula, but students who double-major in mathematics (or other quantitative sciences) and biology (or medicine) remain scarce. We identified the need to educate junior and senior high school students about integrating mathematical and biological skills, through the lens of mathematical oncology, to better prepare students for future careers at the interdisciplinary interface. The High school Internship Program in Integrated Mathematical Oncology (HIP IMO) at Moffitt Cancer Center has so far trained 59 students between 2015 and 2019. We report here on the program structure, training deliverables, curriculum, and outcomes. We hope to promote such interdisciplinary educational activities early in a students career.

scientific communication and education↗

Methods for Processing and Analyzing Images of Vascularized Micro-Organ and Tumor Systems

Our group has developed and validated an advanced microfluidic platform to improve preclinical modeling of healthy and disease states, enabling extended culture and detailed analysis of tissue-engineered miniaturized organ constructs, or "organs-on-chips." Within this system, diverse cell types self-organize into perfused microvascular networks under dynamic flow within tissue chambers, effectively mimicking the structure and function of native tissues. This setup facilitates physiological intravascular delivery of nutrients, immune cells, and therapeutic agents, and creates a realistic microenvironment to study cellular interactions and tissue responses. Known as the vascularized micro-organ (VMO), this adaptable platform can be customized to represent various organ systems or tumors, forming a vascularized micro-tumor (VMT) for cancer studies. The VMO/VMT system closely simulates in vivo nutrient exchange and drug delivery within a 3D microenvironment, establishing a high-fidelity model for drug screening and mechanistic studies in vascular biology, cancer, and organ-specific pathologies. Furthermore, the optical transparency of the device supports high-resolution, real-time imaging of fluorescently labeled cells and molecules within the tissue construct, providing key insights into drug responses, cell interactions, and dynamic processes such as epithelial-mesenchymal transition. To manage the extensive imaging data generated, we created standardized, high-throughput workflows for image analysis. This manuscript presents our image processing and analysis pipeline, utilizing a suite of tools in Fiji/ImageJ to streamline data extraction from the VMO/VMT model, substantially reducing manual processing time. Additionally, we demonstrate how these tools can be adapted for analyzing imaging data from traditional in vitro models and microphysiological systems developed by other researchers.

bioengineering↗

Analysis of Age-Specific Dysregulation of miRNAs in Lung Cancer Via Machine learning: Biomarker Identification and Therapeutic Implications in Patients Aged 60 and Above.

Lung cancer is the leading cause of cancer-related mortality worldwide, predominantly affects older individuals, with non-small cell lung cancer (NSCLC) comprising 85% of cases. Despite advancements in diagnosis and treatment, prognosis for elderly patients remains poor. This study investigates the role of microRNAs (miRNAs) involved in lung cancer, focusing on individuals aged 60 and above. RNA sequencing data from The Cancer Genome Atlas (TCGA) was used to conduct differential expression analysis of miRNA profiles from elderly and senile patient groups. Results showed that out of 1,881 miRNA profiles, 801 were found to be differentially expressed. Filtering for significance identified that 25 miRNAs, with hsa-mir-1911 upregulated and 24, including hsa-mir-196a and hsa-mir-323b found to be downregulated. Studies showed that these miRNAs play roles in apoptosis, senescence, and inflammation. Another Experimental approach in this study, used Machine learning analysis which highlighted key miRNAs, including hsa-mir-181b, hsa-mir-542, hsa-mir-450b, hsa-mir-584, and hsa-mir-21 as crucial in lung cancer biology. Moreover, Functional enrichment analysis revealed their involvement in gene silencing, translational repression, and RNA-induced silencing complex (RISC) regulation. This research identifies the association of miRNAs and aging in lung cancer and finds potential biomarkers that can be helpful in early diagnosis and targets for personalized therapies.

bioinformatics↗

STAG proteins promote cohesin ring loading at R-loops.

Most studies of cohesin function consider the Stromalin Antigen (STAG/SA) proteins as core complex members given their ubiquitous interaction with the cohesin ring. Here, we provide functional data to support the notion that the SA subunit is not a mere passenger in this structure, but instead plays a key role in the localization of cohesin to diverse biological processes and promotes loading of the complex at these sites. We show that in cells acutely depleted for RAD21, SA proteins remain bound to chromatin, cluster in 3D and interact with CTCF, as well as with a wide range of RNA binding proteins involved in multiple RNA processing mechanisms. Accordingly, SA proteins interact with RNA and are localised to R-loops where they contribute to R-loop regulation. Our results place SA1 within R-loop domains upstream of the cohesin complex and reveal a role for SA1 in cohesin loading which is independent of NIPBL, the canonical cohesin loader. We propose that SA1 takes advantage of structural R-loop platforms to link cohesin loading and chromatin structure with diverse functions. Since SA proteins are pan-cancer targets, and R-loops play an increasingly prevalent role in cancer biology, our results have important implications for the mechanistic understanding of SA proteins in cancer and disease.

cell biology↗

Depth Dependent Nanomechanical Analysis of Extracellular Matrix in Multicell Spheroids.

O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=124 SRC=\"FIGDIR/small/193516_ufig1.gif\" ALT=\"Figure 1\">\nView larger version (44K):\norg.highwire.dtl.DTLVardef@4ba6b3org.highwire.dtl.DTLVardef@ad3c2dorg.highwire.dtl.DTLVardef@149e92corg.highwire.dtl.DTLVardef@16b6e51_HPS_FORMAT_FIGEXP M_FIG C_FIG Nanomechanical investigation with Atomic Force Microscope has revealed new details regarding various nanomechanical heterogeneities for cells that are embedded in extracellular matrix in Multicellular spheroidal culture. This investigation sheds new insight into dynamic relationship of cells with their surrounding environment in tumors and 3D multicellular cultures.\n\nNanotechnology has revolutionized the field of cancer biology and has opened new avenues towards understanding nanomechanical variations in rapidly growing tumors. Over the last decade Atomic Force Microscope (AFM) has played an important role in understanding nanomechanical properties of various cancer cell lines. This study is focused on Lewis Lung Carcinoma Cell (LLC) tumors as 3D multicellular spheroid (MS). Such multicellular structures have enabled investigation of various components of tumors in-vitro. To better comprehend mechanical properties of cells and its surrounding extracellular matrix (ECM), depth dependent indentation measurements were conducted with Atomic Force Microscope (AFM). Force-vs-indentation curves were used to create stiffness profiles as function of depth. Here studies were focused on outer most layer i.e. proliferation zone of the spheroid. AFM investigations of sample a MS revealed three nanomechanical topographies, Type A- high modulus due to collagen stress fibers, Type B- high stiffness at cell membrane & ECM interface and Type C - increased modulus due to cell lying deep inside matrix at the a depth of 1.35 microns. Various nanomechanical heterogeneities revealed in this investigation can shed new light in developing correct dosage regime for various tumor dissolving drugs and designing more controlled artificial extracellular matrix systems for replicating tissue growth in-vitro.\n\nShort Statistical SummaryThis article describes nanomechanical characteristics of the cells embedded in extracellular matrix in a multicellular spheroid. The paper contains 6350 words including title page and references. Graphical Content contains 46 words. This article contains 6 Figures and zero tables.

bioengineering↗

Spatial Integration of Multi-Omics Data using the novel Multi-Omics Imaging Integration Toolset

To truly understand the cancer biology of heterogenous tumors in the context of precision medicine, it is crucial to use analytical methodology capable of capturing the complexities of multiple omics levels, as well as the spatial heterogeneity of cancer tissue. Different molecular imaging techniques, such as mass spectrometry imaging (MSI) and spatial transcriptomics (ST) achieve this goal by spatially detecting metabolites and mRNA, respectively. To take full analytical advantage of such multi-omics data, the individual measurements need to be integrated into one dataset. We present MIIT (Multi-Omics Imaging Integration Toolset), a Python framework for integrating spatially resolved multi-omics data. MIITs integration workflow consists of performing a grid projection of spatial omics data, registration of stained serial sections, and mapping of MSI-pixels to the spot resolution of Visium 10x ST data. For the registration of serial sections, we designed GreedyFHist, a registration algorithm based on the Greedy registration tool. We validated GreedyFHist on a dataset of 245 pairs of serial sections and reported an improved registration performance compared to a similar registration algorithm. As a proof of concept, we used MIIT to integrate ST and MSI data on cancer-free tissue from 7 prostate cancer patients and assessed the spot-wise correlation of a gene signature activity for citrate-spermine secretion derived from ST with citrate, spermine, and zinc levels obtained by MSI. We confirmed a significant correlation between gene signature activity and all three metabolites. To conclude, we developed a highly accurate, customizable, computational framework for integrating spatial omics technologies and for registration of serial tissue sections.

bioinformatics↗

Rad9/53BP1 promotes crossover recombination DNA repair by limiting the Sgs1 and Mph1 helicases

A DNA double strand break (DSB) is primed for homologous recombination (HR) repair through the nucleolytic processing (resection) of its ends, leading to the formation of a 3' single-stranded DNA (ssDNA). Generation of the ssDNA is accompanied by the loading of several repair factors, including the ssDNA binding factor RPA and the recombinase Rad51. Then, depending upon the availability and location of a homologous sequence, different types of HR mechanisms can occur. Inefficient or slow HR repair results in the activation of the DNA damage checkpoint (DDC)1. In budding yeast, the 53BP1 ortholog Rad9 acts as a scaffold, mediating signal from upstream kinases Mec1 and Tel1 (ATR and ATM in human) to downstream effectors kinases Rad53 and Chk1 (CHK2 and CHK1 in human). In addition to its role in DDC, Rad9 limits DSB resection 2. Remarkably, this function is conserved in 53BP1, also being implicated in cancer biology in human cells 3,4.\n\nHere we show that Rad9 limits the recruitment of the helicases Sgs1 and Mph1 on to a DSB, promoting Rad51-dependent recombination with long track DNA conversions, crossovers and break-induced replication (BIR). This regulation couples the DDC with the choice and effectiveness of HR sub-pathways, and might be critical to limit genome instability with implication for cancer research.

molecular biology↗

Spatially constrained tumour growth affects the patterns of clonal selection and neutral drift in cancer genomic data

Quantification of the effect of spatial tumour sampling on the patterns of mutations detected in next-generation sequencing data is largely lacking. Here we use a spatial stochastic cellular automaton model of tumour growth that accounts for somatic mutations, selection, drift and spatial constrains, to simulate multi-region sequencing data derived from spatial sampling of a neoplasm. We show that the spatial structure of a solid cancer has a major impact on the detection of clonal selection and genetic drift from bulk sequencing data and single-cell sequencing data. Our results indicate that spatial constrains can introduce significant sampling biases when performing multi-region bulk sampling and that such bias becomes a major confounding factor for the measurement of the evolutionary dynamics of human tumours. We present a statistical inference framework that takes into account the spatial effects of a growing tumour and allows inferring the evolutionary dynamics from patient genomic data. Our analysis shows that measuring cancer evolution using next-generation sequencing while accounting for the numerous confounding factors requires a mechanistic model-based approach that captures the sources of noise in the data. SummarySequencing the DNA of cancer cells from human tumours has become one of the main tools to study cancer biology. However, sequencing data are complex and often difficult to interpret. In particular, the way in which the tissue is sampled and the data are collected, impact the interpretation of the results significantly. We argue that understanding cancer genomic data requires mathematical models and computer simulations that tell us what we expect the data to look like, with the aim of understanding the impact of confounding factors and biases in the data generation step. In this study, we develop a spatial simulation of tumour growth that also simulates the data generation process, and demonstrate that biases in the sampling step and current technological limitations severely impact the interpretation of the results. We then provide a statistical framework that can be used to overcome these biases and more robustly measure aspects of the biology of tumours from the data.

bioinformatics↗

A multiscale functional map of somatic mutations in cancer integrating protein structure and network topology

A major goal of cancer biology is to understand the mechanisms underlying tumorigenesis driven by somatically acquired mutations. Two distinct types of computational methodologies have emerged: one focuses on analyzing clustering of mutations within protein sequences and 3D structures, while the other characterizes mutations by leveraging the topology of protein-protein interaction network. Their insights are largely non-overlapping, offering complementary strengths. Here, we established a unified, end-to-end 3D structurally-informed protein interaction network propagation framework, NetFlow3D, that systematically maps the multiscale mechanistic effects of somatic mutations in cancer. The establishment of NetFlow3D hinges upon the Human Protein Structurome, a comprehensive repository we compiled that incorporates the 3D structures of every single protein as well as the binding interfaces of all known protein interactions in humans. NetFlow3D leverages the Structurome to integrate information across atomic, residue, protein and network levels: It conducts 3D clustering of mutations across atomic and residue levels on protein structures to identify potential driver mutations. It then anisotropically propagates their impacts across the protein interaction network, with propagation guided by the specific 3D structural interfaces involved, to identify significantly interconnected network "modules", thereby uncovering key biological processes underlying disease etiology. Applied to 1,038,899 somatic protein-altering mutations in 9,946 TCGA tumors across 33 cancer types, NetFlow3D identified 1,4444 significant 3D clusters throughout the Human Protein Structurome, of which ~55% would not have been found if using only experimentally-determined structures. It then identified 26 significantly interconnected modules that encompass ~8-fold more proteins than applying standard network analyses. NetFlow3D and our pan-cancer results can be accessed from http://netflow3d.yulab.org.

systems biology↗

Evaluating cancer cell lines as models for metastatic breast cancer

Metastasis is the most common cause of cancer-related death and, as such, there is an urgent need to discover new therapies to treat metastasized cancers. Cancer cell lines are widely-used models to study cancer biology and test drug candidates. However, it is still unknown to what extent they adequately resemble the disease in patients. The recent accumulation of large-scale genomic data in cell lines, mouse models, and patient tissue samples provides an unprecedented opportunity to evaluate the suitability of cell lines for metastatic cancer research. In this work, we used breast cancer as a case study. The comprehensive comparison of the genetic profiles of 57 breast cancer cell lines with those of metastatic breast cancer samples revealed substantial genetic differences. In addition, we identified cell lines that more closely resemble different subtypes of metastatic breast cancer. Surprisingly, a combined analysis of mutation, copy number variation and gene expression data suggested that MDA-MB-231, the most commonly used triple negative cell line for metastatic breast cancer research, had little genomic similarity with Basal-like metastatic breast cancer samples. We further compared cell lines with organoids, a new type of preclinical model which are becoming more popular in recent years. We found that organoids outperformed cell lines in resembling the transcriptome of metastatic breast cancer samples. However, additional differential expression analysis suggested that both types of models could not mimic the effects of tumor microenvironment and meanwhile had their own bias towards modeling specific biological processes. Our work provides a guide of cell line selection in metastasis-related study and sheds light on the potential of organoids in translational research.

bioinformatics↗

Single-Molecule Nanopore Profiling of p53-TAD Conformational Dynamics, Interactions, and Inhibition

Investigating the conformational dynamics of intrinsically disordered proteins (IDPs) is essential to understanding how their structural heterogeneity underlies function and how their dysregulation contributes to diseases. Here, we utilized an MspA nanopore-based approach for studying the conformational dynamics and interactions of IDPs at the single-molecule level. The platform was demonstrated using the intrinsically disordered transactivation domain of tumor suppressor p53 (p53-TAD), one of the important proteins in cancer biology. We showed that MspA can stably capture p53-TAD and resolve up to six distinct current states with frequent interconversions, revealing a rich conformational landscape. The nanopore also detected the effect of a cancer-associated double mutational variant, N29K/N30D. Combining experiments with steered molecular dynamics simulations, we showed that the mutant sampled compact conformational states more frequently than wild type, consistent with previous NMR studies. Importantly, the MspA platform enabled direct monitoring of E3 ligase MDM2 binding to p53-TAD and resolved how this interaction is inhibited by anti-cancer compound epigallocatechin gallate (EGCG). Notably, EGCG stabilizes one of the six states sampled by p53-TAD, providing a mechanistic explanation for its inhibitory effect. Together, these findings demonstrate the promise of the nanopore platform for label-free monitoring of IDP conformational dynamics, modulation, binding and inhibition at single-molecule resolution.

biophysics↗

gtexture: Haralick texture analysis for graphs and its application to biological networks

ObjectiveThe calculation of texture features, such as those derived by Haralick et al., has been traditionally limited to 2D-imaging data. We present the novel derivation of an extension to these texture features that can be applied to graphs and networks and set out to illustrate the potential of these metrics for use in cancer informatics. ApproachWe extend the pixel-based calculation of texture and generate analogous novel metrics for graphs and networks. The graph structures in question must have ordered or continuous node weights/attributes. To demonstrate the utility of these metrics in cancer biology, we demonstrate these metrics can distinguish different fitness landscapes, gene co-expression and regulatory networks, and protein interaction networks with both simulated and publicly available experimental gene expression data. Main ResultsWe demonstrate that texture features are informative of graph structure and analyse their sensitivity to discretization parameters and node label noise. We demonstrate that graph texture varies across multiple network types including fitness landscapes and large protein interaction networks with experimental expression data. We show the ability of these texture metrics, calculated on specific protein interaction subnetworks, to classify cell line expression by lineage, generating classifiers with 82% and 89% accuracy. SignificanceGraph texture features are a novel second order graph metric that can distinguish cancer types and topologies of evolutionary landscapes. It appears that no similar metrics currently exist and thus we open up the potential derivation of more metrics for the classification and analysis of network-structured data. This may be particularly useful in the complex setting of cancer, where large graph and network structures underlie the omics data generated. Network-based data underlies drug discovery, drug response prediction and single-cell dynamics and thus these metrics provide an additional tool in tackling these problems in cancer.

bioinformatics↗